Fibrogen Stock Price on August 9, 2018
| FGEN Stock | USD 1.17 0.10 7.87% |
Below is the normalized historical share price chart for FibroGen extending back to November 14, 2014. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of FibroGen stands at 1.17, as last reported on the 18th of April 2024, with the highest price reaching 1.29 and the lowest price hitting 1.14 during the day.
If you're considering investing in FibroGen Stock, it is important to understand the factors that can impact its price. FibroGen is out of control given 3 months investment horizon. FibroGen secures Sharpe Ratio (or Efficiency) of 0.11, which denotes the company had a 0.11% return per unit of standard deviation over the last 3 months. We were able to analyze and collect data for twenty-nine different technical indicators, which can help you to evaluate if expected returns of 1.52% are justified by taking the suggested risk. Use FibroGen Mean Deviation of 8.13, semi deviation of 9.29, and Downside Deviation of 11.03 to evaluate company specific risk that cannot be diversified away.
At this time, FibroGen's Liabilities And Stockholders Equity is very stable compared to the past year. As of the 18th of April 2024, Capital Stock is likely to grow to about 1 M, though Total Stockholder Equity is likely to grow to (194 M). . As of the 18th of April 2024, Price To Sales Ratio is likely to drop to 0.55. In addition to that, Price Earnings Ratio is likely to drop to -0.32. FibroGen Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 14th of November 2014 | 200 Day MA 1.319 | 50 Day MA 1.9899 | Beta 0.736 |
FibroGen |
Sharpe Ratio = 0.1078
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | FGEN | |||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 14.14 actual daily | 96 96% of assets are less volatile |
Expected Return
| 1.52 actual daily | 29 71% of assets have higher returns |
Risk-Adjusted Return
| 0.11 actual daily | 8 92% of assets perform better |
Based on monthly moving average FibroGen is performing at about 8% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of FibroGen by adding it to a well-diversified portfolio.
Price Book 53.8258 | Enterprise Value Ebitda (0.17) | Price Sales 0.869 | Shares Float 83 M | Wall Street Target Price 1.75 |
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
About FibroGen Stock history
FibroGen investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for FibroGen is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in FibroGen will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing FibroGen stock prices may prove useful in developing a viable investing in FibroGen
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 97.3 M | 78.2 M | |
| Net Loss | -264.3 M | -251.1 M |
FibroGen Quarterly Net Working Capital |
|
FibroGen Stock Technical Analysis
FibroGen technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
FibroGen Period Price Range
FibroGen April 18, 2024 Market Strength
Market strength indicators help investors to evaluate how FibroGen stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading FibroGen shares will generate the highest return on investment. By undertsting and applying FibroGen stock market strength indicators, traders can identify FibroGen entry and exit signals to maximize returns
FibroGen Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for FibroGen's price direction in advance. Along with the technical and fundamental analysis of FibroGen Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of FibroGen to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0826 | |||
| Jensen Alpha | 1.36 | |||
| Total Risk Alpha | 0.5927 | |||
| Sortino Ratio | 0.1398 | |||
| Treynor Ratio | 0.3153 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in FibroGen. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. To learn how to invest in FibroGen Stock, please use our How to Invest in FibroGen guide.Note that the FibroGen information on this page should be used as a complementary analysis to other FibroGen's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Complementary Tools for FibroGen Stock analysis
When running FibroGen's price analysis, check to measure FibroGen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy FibroGen is operating at the current time. Most of FibroGen's value examination focuses on studying past and present price action to predict the probability of FibroGen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move FibroGen's price. Additionally, you may evaluate how the addition of FibroGen to your portfolios can decrease your overall portfolio volatility.
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |
Is FibroGen's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of FibroGen. If investors know FibroGen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about FibroGen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.536 | Earnings Share (2.92) | Revenue Per Share 1.518 | Quarterly Revenue Growth (0.21) | Return On Assets (0.36) |
The market value of FibroGen is measured differently than its book value, which is the value of FibroGen that is recorded on the company's balance sheet. Investors also form their own opinion of FibroGen's value that differs from its market value or its book value, called intrinsic value, which is FibroGen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because FibroGen's market value can be influenced by many factors that don't directly affect FibroGen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between FibroGen's value and its price as these two are different measures arrived at by different means. Investors typically determine if FibroGen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, FibroGen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.